FORMULATIONS OPHTALMIQUES D'INHIBITEURS DE TYROSINE KINASE, LEURS PROCEDES D'UTILISATION, ET LEURS PROCEDES DE PREPARATION

• 收藏
• 分享

专利权人:

ALLGENESIS BIOTHERAPEUTICS INC.

发明人:

NGUYEN, TAN,LAI, CHIN-YU

申请号：

CA2989121

公开号：

CA2989121A1

申请日:

2016.05.27

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

Ophthalmic formulations containing tyrosine kinase inhibitors, such as Nintedanib, Axitinib, Sorafenib, and Pazopanib are described. The ophthalmic formulations can contain microparticles or nanoparticles of the tyrosine kinase inhibitor. Also described are methods of using the ophthalmic formulations for treating ocular surface diseases, such pterygium, including recurrent pterygium, and hyperemia associated with pterygium.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/